CNS cancer immunity cycle and strategies to target this for glioblastoma

Immunotherapeutics have revolutionized the management of solid malignancies over the last few years. Nevertheless, despite relative successes of checkpoint inhibitors in numerous solid tumour types, success in tumours of the central nervous system (CNS) has been lacking. There are several possible r...

Descripción completa

Detalles Bibliográficos
Autores principales: Ameratunga, Malaka, Coleman, Niamh, Welsh, Liam, Saran, Frank, Lopez, Juanita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5978266/
https://www.ncbi.nlm.nih.gov/pubmed/29854316
http://dx.doi.org/10.18632/oncotarget.24896

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5978266/
https://www.ncbi.nlm.nih.gov/pubmed/29854316
http://dx.doi.org/10.18632/oncotarget.24896

Ejemplares similares